
NE-100
CAS No. 149860-29-7
NE-100( NE 100 | NE100 )
Catalog No. M12082 CAS No. 149860-29-7
A potent, selective, and orally active sigma-1 receptor antagonist with Ki of 1.03 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameNE-100
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, and orally active sigma-1 receptor antagonist with Ki of 1.03 nM.
-
DescriptionA potent, selective, and orally active sigma-1 receptor antagonist with Ki of 1.03 nM; dispalys 205-fold selectivity over sigma-2, 1,000-fold selectivity over D1, D2, PCP, α1, 5-HT1A and 5-HT2 receptors; shows antipsychotic activity in vivo.Schizophrenia Phase 2 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsNE 100 | NE100
-
PathwayAutophagy
-
TargetSigma receptor
-
RecptorSigma Receptor
-
Research AreaNeurological Disease
-
IndicationSchizophrenia
Chemical Information
-
CAS Number149860-29-7
-
Formula Weight355.51
-
Molecular FormulaC23H33NO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name4-Methoxy-3-(2-phenylethoxy)-N,N-dipropylbenzeneethanamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Nakazato A, et al. J Med Chem. 1999 Mar 25;42(6):1076-87.
2. Berardi F, et al. Bioorg Med Chem. 2001 May;9(5):1325-35.
3. Ogawa S, et al. Eur J Pharmacol. 1994 Sep 22;263(1-2):9-15.
molnova catalog



related products
-
σ1 Receptor antagoni...
σ1 Receptor antagonist-1 is a selective sigma 1 receptor antagonist.
-
KSK67
KSK67 is a selective dual antagonist of sigma-2 and histamine H3 receptors with inhibitory effects on H3 receptors, sigma-1, and sigma-2 receptors, with Ki values of 3.2, 1531, and 101 nM, respectively.
-
Lu-28-179
Siramesine(Lu 28-179) hydrochloride is a selective sigma-2 receptor agonist, which has been shown to trigger cell death of Y cells and to exhibit a potent anticancer activity in vivo.